Popular Articles

How Consumers Continue Enjoying Their Favorite Experiences
We"ve all experienced listening to a song until we can"t stand it. A new study in the Journal of Consumer Research may help people continue to enjoy the products and experiences they once loved.
generic viagra online
Addex Partner Starts First-Ever Clinical Trial Of An MGluR Positive Allosteric Modulator
Allosteric modulation company Addex Pharmaceuticals (SWISS: ADXN) announced today that its partner Ortho-McNeil- Janssen Pharmaceuticals Inc. (OMP) has started Phase I testing of ADX71149, a metabotropic glutamate receptor 2 (mGluR2) positive allosteric modulator (PAM). This product, which has potential to treat schizophrenia, anxiety, depression and other CNS disorders, is the first PAM of any mGluR subtype to enter clinical trials. Targeting mGluR2 with a PAM is a novel approach that may offer advantages over classical drug approaches. In reaching this milestone, Addex received a EUR 1 million payment from OMP and remains eligible for additional development milestones and royalties.
News of the day
UCLA Scientists Identify How Immune Cells May Help Predict Alzheimer's Risk; MP Biomedicals Granted Rights To Further Develop Screening Tool
UCLA scientists have discovered a way to measure the amount of amyloid beta that is being absorbed by immune cells in the blood. Amyloid beta forms the plaques considered the hallmark of Alzheimer"s disease, and if the immune system isn"t adequately clearing amyloid beta, it may indicate Alzheimer"s risk, according to the researchers.
Health Insurance

Survey: Speech Therapy Helps, But People Who Stutter Suffer Discrimination

Four out of 10 adults who stutter have been denied a job or promotion and 82 percent of children who stutter have been bullied or teased, according to a new survey by the National Stuttering Association. People who stutter make up about 1 percent of the population. Results of the survey were announced today at the organization"s national conference in Scottsdale, AZ. While there is no cure for stuttering, the survey of 1,235 people showed that speech therapy helps the majority of people who stutter. However, 30 percent of parents have received bad advice about stuttering treatment from pediatricians and speech therapists, and 14 percent of children who stutter have been denied speech therapy in school. The survey also found that: -- Stuttering interferes with work, school and family life. Children and adults who stutter often avoid speaking situations, feel embarrassed when people find out they stutter, and do not discuss their stuttering with family, friends and co-workers. -- People who participate in stuttering support groups report fewer negative effects of stuttering and more successful speech therapy than those who do not. Support groups help people improve their self-confidence and develop positive attitudes about speaking and stuttering. -- Speech therapies that change attitudes toward speaking and stuttering are more successful than therapies that focus on speech mechanics. -- People who had speech therapy from a speech-language pathologist who is a Board Recognized Specialist in Fluency Disorders had more successful speech therapy than those who did not. -- Alternative treatments for stuttering, such as psychological counseling, prescription medication and assistive devices, help some people but are significantly less effective than speech therapy. Participants in the May 2009 online survey were National Stuttering Association members, participants in the organization"s programs and visitors to its web site. The National Stuttering Association is a non-profit organization that helps adults and children who stutter with support activities, educational programs, publications and advocacy. It"s the largest organization of its type with more than 100 local support groups across the U.S. National Stuttering Association


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):